Skip to main content
Erschienen in: Inflammation 2/2016

16.02.2016 | ORIGINAL ARTICLE

Morphine Suppresses T helper Lymphocyte Differentiation to Th1 Type Through PI3K/AKT Pathway

verfasst von: Mao Mao, Yanning Qian, Jie Sun

Erschienen in: Inflammation | Ausgabe 2/2016

Einloggen, um Zugang zu erhalten

Abstract

To investigate the effect of morphine on T helper lymphocyte differentiation and PI3K/AKT pathway mechanism, CD4+ lymphocytes were treated by phorbol-myristate-acetate (25 ng/ml) (PMA) plus ionomycin (1 μg/ml) in the presence of various concentrations of morphine (25, 50, 100, 200 ng/ml) for 4 h. Th1 and Th2 subsets, supernatant cytokines, and PI3K, AKT, and protein kinase C-theta (PKC-θ) levels were detected. The Th1 cell percentage, Th1-derived cytokines, and ratio of Th1/Th2 decreased in the presence of morphine in a concentration-dependent manner. However, Th2 cell percentage kept stable after morphine treatment. The phosphorylation of PI3K and AKT decreased, but the phosphorylation of PKC-θ did not change in the presence of morphine. The decreased percentage of Th1 cells and ratio of Th1/Th2 was recovered by naloxone concentration-dependently. Morphine can inhibit the differentiation of Th1 lymphocytes and decrease the ratio of Th1/Th2 via the pathway of PI3K/AKT. The effect can be inhibited by naloxone.
Literatur
1.
Zurück zum Zitat Knutson, K.L., and M.L. Disis. 2005. Tumor antigen-specific T helper cells in cancer immunity and immunotherapy. Cancer Immunology, Immunotherapy 54: 721–8.CrossRefPubMed Knutson, K.L., and M.L. Disis. 2005. Tumor antigen-specific T helper cells in cancer immunity and immunotherapy. Cancer Immunology, Immunotherapy 54: 721–8.CrossRefPubMed
2.
Zurück zum Zitat De Monte, L., M. Reni, E. Tassi, et al. 2011. Intratumor T helper type 2 cell infiltrate correlates with cancer-associated fibroblast thymic stromal lymphopoietin production and reduced survival in pancreatic cancer. The Journal of Experimental Medicine 208: 469–78.CrossRefPubMedPubMedCentral De Monte, L., M. Reni, E. Tassi, et al. 2011. Intratumor T helper type 2 cell infiltrate correlates with cancer-associated fibroblast thymic stromal lymphopoietin production and reduced survival in pancreatic cancer. The Journal of Experimental Medicine 208: 469–78.CrossRefPubMedPubMedCentral
3.
Zurück zum Zitat Tosolini, M., A. Kirilovsky, B. Mlecnik, et al. 2011. Clinical impact of different classes of infiltrating T cytotoxic and helper cells (Th1, th2, treg, th17) in patients with colorectal cancer. Cancer Research 71: 1263–71.CrossRefPubMed Tosolini, M., A. Kirilovsky, B. Mlecnik, et al. 2011. Clinical impact of different classes of infiltrating T cytotoxic and helper cells (Th1, th2, treg, th17) in patients with colorectal cancer. Cancer Research 71: 1263–71.CrossRefPubMed
4.
Zurück zum Zitat Ubukata, H., G. Motohashi, T. Tabuchi, et al. 2010. Evaluations of interferon-γ/interleukin-4 ratio and neutrophil/lymphocyte ratio as prognostic indicators in gastric cancer patients. Journal of Surgical Oncology 102: 742–7.CrossRefPubMed Ubukata, H., G. Motohashi, T. Tabuchi, et al. 2010. Evaluations of interferon-γ/interleukin-4 ratio and neutrophil/lymphocyte ratio as prognostic indicators in gastric cancer patients. Journal of Surgical Oncology 102: 742–7.CrossRefPubMed
5.
Zurück zum Zitat Pollizzi, K.N., and J.D. Powell. 2014. Integrating canonical and metabolic signalling programmes in the regulation of T cell responses. Nature Reviews Immunology 14: 435–46.CrossRefPubMedPubMedCentral Pollizzi, K.N., and J.D. Powell. 2014. Integrating canonical and metabolic signalling programmes in the regulation of T cell responses. Nature Reviews Immunology 14: 435–46.CrossRefPubMedPubMedCentral
6.
Zurück zum Zitat Ding, R., J. Tang, H. Gao, et al. 2012. New methymycin derivatives of Streptomyces venezuelae ATCC 15439 and their inhibitory effects on human T cell proliferation mediated by PMA/ionomycin. Archives of Pharmacal Research 35: 1567–72.CrossRefPubMed Ding, R., J. Tang, H. Gao, et al. 2012. New methymycin derivatives of Streptomyces venezuelae ATCC 15439 and their inhibitory effects on human T cell proliferation mediated by PMA/ionomycin. Archives of Pharmacal Research 35: 1567–72.CrossRefPubMed
7.
Zurück zum Zitat Gao, M., J. Sun, W. Jin, et al. 2012. Morphine, but not ketamine, decreases the ratio of Th1/Th2 in CD4-positive cells through T-bet and GATA3. Inflammation 35: 1069–77.CrossRefPubMed Gao, M., J. Sun, W. Jin, et al. 2012. Morphine, but not ketamine, decreases the ratio of Th1/Th2 in CD4-positive cells through T-bet and GATA3. Inflammation 35: 1069–77.CrossRefPubMed
8.
Zurück zum Zitat Kraus, J. 2012. Expression and functions of μ-opioid receptors and cannabinoid receptors type 1 in T lymphocytes. Annals of the New York Academy of Sciences 1261: 1–6.CrossRefPubMed Kraus, J. 2012. Expression and functions of μ-opioid receptors and cannabinoid receptors type 1 in T lymphocytes. Annals of the New York Academy of Sciences 1261: 1–6.CrossRefPubMed
9.
Zurück zum Zitat Madishetti, S., N. Schneble, C. König, et al. 2014. PI3Kγ integrates cAMP and Akt signalling of the μ-opioid receptor. British Journal of Pharmacology 171: 3328–37.CrossRefPubMedPubMedCentral Madishetti, S., N. Schneble, C. König, et al. 2014. PI3Kγ integrates cAMP and Akt signalling of the μ-opioid receptor. British Journal of Pharmacology 171: 3328–37.CrossRefPubMedPubMedCentral
10.
Zurück zum Zitat Higuchi, S., M. Ii, P. Zhu, et al. 2012. Delta-opioid receptor activation promotes mesenchymal stem cell survival via PKC/STAT3 signaling pathway. Circulation Journal 76: 204–12.CrossRefPubMed Higuchi, S., M. Ii, P. Zhu, et al. 2012. Delta-opioid receptor activation promotes mesenchymal stem cell survival via PKC/STAT3 signaling pathway. Circulation Journal 76: 204–12.CrossRefPubMed
11.
Zurück zum Zitat Cook, K.D., and J. Miller. 2010. TCR-dependent translational control of GATA-3 enhances Th2 differentiation. Journal of Immunology 185: 3209–16.CrossRef Cook, K.D., and J. Miller. 2010. TCR-dependent translational control of GATA-3 enhances Th2 differentiation. Journal of Immunology 185: 3209–16.CrossRef
12.
Zurück zum Zitat Chen, H., T. Fu, W.K. Suh, et al. 2014. CD4 T cells require ICOS-mediated PI3K signaling to increase T-Bet expression in the setting of anti-CTLA-4 therapy. Cancer Immunologic Research 2: 167–76.CrossRef Chen, H., T. Fu, W.K. Suh, et al. 2014. CD4 T cells require ICOS-mediated PI3K signaling to increase T-Bet expression in the setting of anti-CTLA-4 therapy. Cancer Immunologic Research 2: 167–76.CrossRef
13.
Zurück zum Zitat Gao, M., W. Jin, Y. Qian, et al. 2011. Effect of N-methyl-D-aspartate receptor antagonist on T helper cell differentiation induced by phorbol-myristate-acetate and ionomycin. Cytokine 56: 458–65.CrossRefPubMed Gao, M., W. Jin, Y. Qian, et al. 2011. Effect of N-methyl-D-aspartate receptor antagonist on T helper cell differentiation induced by phorbol-myristate-acetate and ionomycin. Cytokine 56: 458–65.CrossRefPubMed
14.
Zurück zum Zitat Lee, K., P. Gudapati, S. Dragovic, et al. 2010. Mammalian target of rapamycin protein complex 2 regulates differentiation of Th1 and Th2 cell subsets via distinct signaling pathways. Immunity 32: 743–53.CrossRefPubMedPubMedCentral Lee, K., P. Gudapati, S. Dragovic, et al. 2010. Mammalian target of rapamycin protein complex 2 regulates differentiation of Th1 and Th2 cell subsets via distinct signaling pathways. Immunity 32: 743–53.CrossRefPubMedPubMedCentral
15.
Zurück zum Zitat Marsland, B.J., T.J. Soos, G. Späth, et al. 2004. Protein kinase C theta is critical for the development of in vivo T helper (Th)2 cell but not Th1 cell responses. The Journal of Experimental Medicine 200: 181–9.CrossRefPubMedPubMedCentral Marsland, B.J., T.J. Soos, G. Späth, et al. 2004. Protein kinase C theta is critical for the development of in vivo T helper (Th)2 cell but not Th1 cell responses. The Journal of Experimental Medicine 200: 181–9.CrossRefPubMedPubMedCentral
16.
Zurück zum Zitat Zhang, L., J.S. Belkowski, T. Briscoe, et al. 2012. Regulation of mu opioid receptor expression in developing T cells. Journal of Neuroimmune Pharmacology 7: 835–42.CrossRefPubMedPubMedCentral Zhang, L., J.S. Belkowski, T. Briscoe, et al. 2012. Regulation of mu opioid receptor expression in developing T cells. Journal of Neuroimmune Pharmacology 7: 835–42.CrossRefPubMedPubMedCentral
17.
Zurück zum Zitat Roy, S., F. Ethuin, C. Bourgeois, et al. 2004. Chronic morphine treatment differentiates T helper cells to Th2 effector cells by modulating transcription factors GATA 3 and T-bet. Journal of Neuroimmunology 147: 78–81.CrossRefPubMed Roy, S., F. Ethuin, C. Bourgeois, et al. 2004. Chronic morphine treatment differentiates T helper cells to Th2 effector cells by modulating transcription factors GATA 3 and T-bet. Journal of Neuroimmunology 147: 78–81.CrossRefPubMed
18.
Zurück zum Zitat Hammoud, H.A., G. Aymard, P. Lechat, et al. 2011. Relationships between plasma concentrations of morphine, morphine-3-glucuronide, morphine-6-glucuronide, and intravenous morphine titration outcomes in the postoperative period. Fundamental and Clinical Pharmacology 25: 518–27.CrossRefPubMed Hammoud, H.A., G. Aymard, P. Lechat, et al. 2011. Relationships between plasma concentrations of morphine, morphine-3-glucuronide, morphine-6-glucuronide, and intravenous morphine titration outcomes in the postoperative period. Fundamental and Clinical Pharmacology 25: 518–27.CrossRefPubMed
19.
Zurück zum Zitat Greeneltch, K.M., A.E. Kelly-Welch, Y. Shi, et al. 2005. Chronic morphine treatment promotes specific Th2 cytokine production by Murine T cells in vitro via a Fas/Fas ligand-dependent mechanism. The Journal of Immunology 175: 4999–5005.CrossRefPubMed Greeneltch, K.M., A.E. Kelly-Welch, Y. Shi, et al. 2005. Chronic morphine treatment promotes specific Th2 cytokine production by Murine T cells in vitro via a Fas/Fas ligand-dependent mechanism. The Journal of Immunology 175: 4999–5005.CrossRefPubMed
20.
Zurück zum Zitat Roy, S., J. Wang, R. Charboneau, et al. 2005. Morphine induces CD4+ T cell IL-4 expression through an adenylyl cyclase mechanism independent of the protein kinase a pathway. Journal of Immunology 175: 6361–6367.CrossRef Roy, S., J. Wang, R. Charboneau, et al. 2005. Morphine induces CD4+ T cell IL-4 expression through an adenylyl cyclase mechanism independent of the protein kinase a pathway. Journal of Immunology 175: 6361–6367.CrossRef
Metadaten
Titel
Morphine Suppresses T helper Lymphocyte Differentiation to Th1 Type Through PI3K/AKT Pathway
verfasst von
Mao Mao
Yanning Qian
Jie Sun
Publikationsdatum
16.02.2016
Verlag
Springer US
Erschienen in
Inflammation / Ausgabe 2/2016
Print ISSN: 0360-3997
Elektronische ISSN: 1573-2576
DOI
https://doi.org/10.1007/s10753-016-0310-x

Weitere Artikel der Ausgabe 2/2016

Inflammation 2/2016 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.